Skip to main content

4D pharma PLC (LBPS)

NASDAQ: LBPS · Delayed Price · USD
7.16
-0.09 (-1.24%)
After-hours:Oct 25, 2021 4:00 PM EDT
7.25
-0.17 (-2.29%)
At close: Oct 25, 4:00 PM

Total Valuation

4D pharma has a market cap or net worth of $161.62 million. The enterprise value is $141.88 million.

Market Cap161.62M
Enterprise Value141.88M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

4D pharma has 22.54 million shares outstanding.

Shares Outstanding22.54M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)0.99%
Float15.32M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio329.84
PB Ratio4.07
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.

EV / Earningsn/a
EV / Sales289.56
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.03.

Current Ratio4.22
Quick Ratio3.37
Debt / Equity0.03
Debt / EBITDA-0.01
Debt / FCF-0.05

Financial Efficiency

Return on Equity (ROE)-190.30%
Return on Assets (ROA)-154.50%
Return on Capital (ROIC)-819.80%
Revenue Per Employee$5,326
Profits Per Employee-$735,728
Employee Count92
Asset Turnover0.01
Inventory Turnovern/a

Taxes

Income Tax-3.95M
Effective Tax Rate5.52%

Stock Price Statistics

The stock price has decreased by -49.00% in the last 52 weeks. The beta is 2.99, so 4D pharma's price volatility has been higher than the market average.

Beta (1Y)2.99
52-Week Price Change-49.00%
50-Day Moving Average7.27
200-Day Moving Average9.79
Average Volume (30 Days)24,432

Short Selling Information

Short Interest5,049
Short % of Shares Out0.02%
Short % of Float0.03%
Short Ratio (days to cover)0.12

Income Statement

In the last 12 months, 4D pharma had revenue of $490,000 and -$67.69 million in losses. Earnings per share was -$4.86.

Revenue490,000
Gross Profit490,000
Operating Income-71.15M
Pretax Income-71.64M
Net Income-67.69M
EBITDA-70.36M
EBIT-71.47M
Earnings Per Share (EPS)-$4.86
Full Income Statement

Balance Sheet

The company has $20.75 million in cash and $1.01 million in debt, giving a net cash position of $19.74 million or $0.88 per share.

Cash & Cash Equivalents20.75M
Total Debt1.01M
Net Cash19.74M
Net Cash Per Share$0.88
Book Value39.66M
Book Value Per Share1.76
Working Capital22.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$20.23 million and capital expenditures -$120,000, giving a free cash flow of -$20.35 million.

Operating Cash Flow-20.23M
Capital Expenditures-120,000
Free Cash Flow-20.35M
FCF Per Share-$0.90
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -14,519.39% and -13,813.67%.

Gross Margin100.00%
Operating Margin-14,519.39%
Pretax Margin-14,620.20%
Profit Margin-13,813.67%
EBITDA Margin-14,359.80%
EBIT Margin-14,585.92%
FCF Margin-4,152.65%

Dividends & Yields

4D pharma does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-41.88%
FCF Yield-12.59%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a